Elite 50% OFF Act now – get top investing tools Register Now!

Insight Molecular Diagnostics Inc.

Contributing Author

Recent Articles by Insight Molecular Diagnostics Inc.

Nov-10	IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch IMDX GlobeNewswire
Nov-03	iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week IMDX GlobeNewswire
Oct-13	iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch IMDX GlobeNewswire
Oct-06	iMDx Reports Kidney Transplant Patient Achieved 'Immune Reset' with Novel Therapy and GraftAssure Monitoring IMDX GlobeNewswire
Sep-24	Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando IMDX GlobeNewswire
Sep-08	Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database IMDX GlobeNewswire
Sep-08	IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants IMDX GlobeNewswire
Aug-26	iMDx to Participate in NYC Investment Conferences September 8 - 11 IMDX GlobeNewswire
Aug-11	IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch IMDX GlobeNewswire
Aug-04	iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference IMDX GlobeNewswire
Jul-30	IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients IMDX GlobeNewswire
Jul-28	iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025 IMDX GlobeNewswire
Jun-23	iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing IMDX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.